Annual report pursuant to Section 13 and 15(d)

Net Loss per Share of Common Stock (Details) - Schedule of warrants that are exercisable into shares of stock

v3.22.2.2
Net Loss per Share of Common Stock (Details) - Schedule of warrants that are exercisable into shares of stock - USD ($)
 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Schedule Of Warrants That Are Exercisable Into Shares Of Stock Abstract    
Numerator - basic and diluted loss per share net loss $ 2,523,277 $ (3,479,824)
Deemed dividend on Series B stock 381,310 4,085,925
Net loss available to common stockholders $ 2,904,587 $ (7,565,749)
Denominator – basic and diluted loss per share – weighted average common shares outstanding (in Shares) 87,521,595 71,090,407
Basic and diluted earnings per share (in Dollars per share) $ (0.03) $ (0.11)